End-stage renal disease: a risk factor of deep neck infection – a nationwide follow-up study in Taiwan

BMC Infectious Diseases

Table 3 Analysis of therapeutic interventions, complications and prognostic outcomes in patients with DNI

Characteristic	ESRD-DNI		Non-ESRD-DNI		p-value
Characteristic	N	%	N	%	p-value
Total	280		194
Therapy					0.394^b
antibiotic	208	74.3	146	75.3
aspiration	4	1.4	6	3.1
surgery	68	24.3	42	21.7
Tracheostomy	10	3.6	7	3.6	0.983^c
Hospitalization (mean ± SD)	11.1 ± 14.7		9.7 ± 12.7		0.269^d
ICU care	39	13.9	14	7.2	0.023^c
Mediastinitis	7	2.5	2	1.0	0.249^c
Mediastinitis-Mortality	3	1.1	1	0.5	0.515^c
Mortality^a	26	8.0	6	2.9	0.021^c

^aMortality occurrence after DNI
^bPearson’s chi-squared tests
^cFisher exact tests
^dStudent’s t tests
Abbreviations: SD standard deviation, ICU intensive care unit
Table 3 demonstrated the analysis of three therapeutic methods used for treatment of DNI, the indicators used for evaluating the interventions, complications and prognostic outcomes in both cohorts. There was no difference in the methods for treatment and the proportion of three therapies resembled in both cohorts. Tracheostomy rate, duration of hospitalization and mediastinal complication did not differ in both cohorts; however, the proportion of patients receiving ICU care was higher among those with ESRD and DNI. ESRD group had significantly higher mortality rate than non-ESRD group (p = 0.032)

ISSN: 1471-2334